/
NNOX
$1.21+$0.12 (+11.01%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$75.9M
70M shares
52-week range
$0.73 – $5.69
10% from low
Exchange
NASDAQ
CS
Borrow rate
23.22%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-30.84
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1.3M | $8.6M | $9.9M | $11.3M | $13.0M |
| Cost of revenue | $35.0K | $53.0K | $208.0K | $2.8M | $15.5M | $16.5M | $21.9M | $25.8M |
| Gross profit | −$35.0K | −$53.0K | −$208.0K | −$1.5M | −$6.9M | −$6.6M | −$10.6M | −$12.8M |
| Gross margin | — | — | — | -116.0% | -80.2% | -66.6% | -94.0% | -98.2% |
| R&D | $672.0K | $2.7M | $9.2M | $17.1M | $26.5M | $26.0M | $20.2M | $19.2M |
| Operating income | −$1.9M | −$22.6M | −$43.9M | −$61.6M | −$109.7M | −$62.6M | −$56.7M | −$60.7M |
| EBITDA | −$1.9M | −$22.5M | −$43.6M | −$59.3M | −$75.7M | −$47.7M | −$45.0M | −$49.0M |
| Net income | −$1.9M | −$22.6M | −$43.5M | −$61.8M | −$105.2M | −$60.8M | −$53.5M | −$75.0M |
| Net margin | — | — | — | -4739.1% | -1226.9% | -613.6% | -474.3% | -576.1% |
| EPS (diluted) | -0.06 | -0.49 | -1.22 | -1.28 | -2.01 | -1.08 | -0.91 | -1.16 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $29M | $-0.65 | $-0.72–$-0.58 | 2 |
| 2027 | $55M | $-0.35 | $-0.41–$-0.27 | 1 |
| 2028 | $109M | $-0.13 | $-0.17–$-0.08 | 2 |
| 2029 | $184M | $0.23 | $0.17–$0.27 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
NANO-X IMAGING LTD Ordinary Shares
Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.
www.nanox.vision- Employees
- 197
- IPO / List date
- Aug 21, 2020
Held by traders on TradeandTell
No one on the platform currently holds NNOX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NNOX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NNOX yet.
